{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:52:12Z","timestamp":1793958732945,"version":"4.8.0"},"reference-count":23,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"1","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Oncol Pract"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Cytokine release syndrome (CRS) of any grade occurs in 56%-80% of bispecific antibodies (BsAbs) used in multiple myeloma (MM). Risk mitigation strategies are required to expedite escalation of care if toxicities develop. The rarity of grade 3 or 4 CRS compels protocolized outpatient management of BsAbs as outpatient practice may avoid hospital admissions and costly resource utilization without compromising safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>Patients with MM who received BsAb step-up dosing (SUD) from August 23, 2023, to March 29, 2024, were enrolled. Baseline demographics, patient outcomes, and CRS management were reviewed to assess the safety of outpatient practice. Resource utilization was also analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>In this study, 34 patients received outpatient SUD of BsAbs (teclistamab n = 17, talequetamab n = 17) with 16 remaining outpatient throughout the entire SUD period. CRS occurred in seven patients who did not require hospitalization, demonstrating the safety of outpatient management of BsAb toxicity, regardless of low-grade CRS. CRS was observed in 24 patients (maximum grade 2) and immune effector cell\u2013associated neurotoxicity syndrome in four patients (maximum grade 3). All patients with CRS received steroids, including 12 patients at home when instructed. Tocilizumab was given to 13 patients, accounting for 18 doses. If all doses of BsAbs and tocilizumab were given outpatient, the medication margin would be $115,004 in US dollars (USD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>An outpatient-based practice for BsAb administration demonstrated safety and cost savings. The description of our practice and results of this study provide valuable insights into the safety, feasibility, and resource stewardship of outpatient management of BsAbs. Future research should attempt to predict and stratify CRS risk to deliver a tailored supportive strategy and continued increase of outpatient management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/op-24-00930","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:59:06Z","timestamp":1744732746000},"page":"83-90","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":7,"title":["Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization"],"prefix":"10.1200","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2735-5608","authenticated-orcid":false,"given":"Jenna R.","family":"Puttkammer","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2146-5766","authenticated-orcid":false,"given":"Jason N.","family":"Barreto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1954-4414","authenticated-orcid":false,"given":"Chelsee J.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Finance, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5667-4543","authenticated-orcid":false,"given":"Adrienne N.","family":"Nedved","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine L.","family":"Wilson-Miller","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin C.","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy M.","family":"Holmes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison R.","family":"Kosobud","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4342-364X","authenticated-orcid":false,"given":"Prashant","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3853-5196","authenticated-orcid":false,"given":"Morie A.","family":"Gertz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dingli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6890-969X","authenticated-orcid":false,"given":"Wilson I.","family":"Gonsalves","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-9284","authenticated-orcid":false,"given":"Shaji K.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne R.","family":"Hayman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taxiarchis V.","family":"Kourelis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0240-0326","authenticated-orcid":false,"given":"Rahma","family":"Warsame","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-9658","authenticated-orcid":false,"given":"Moritz","family":"Binder","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5335-9533","authenticated-orcid":false,"given":"Joselle","family":"Cook","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1556-6416","authenticated-orcid":false,"given":"Yi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5736-2460","authenticated-orcid":false,"given":"Tyler B.","family":"Sandahl","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203478"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204591"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02528-9"},{"key":"e_1_3_5_5_2","volume-title":"TECVAYLI [prescribing information]","year":"2024","unstructured":"TECVAYLI [prescribing information]. Horsham, PA, Janssen Biotech, Inc. 2024. https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/TECVAYLI-pi.pdf"},{"key":"e_1_3_5_6_2","volume-title":"TALVEY [package insert]","year":"2023","unstructured":"TALVEY [package insert]. Horsham, PA, Janssen Biotech, Inc. 2023. https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/TALVEY-pi.pdf"},{"key":"e_1_3_5_7_2","volume-title":"ELREXFIO [package insert]","year":"2023","unstructured":"ELREXFIO [package insert]. New York, NY, Pfizer Inc. 2023. https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=19669"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.136"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"e_1_3_5_10_2","volume-title":"Management of bispecific antibody therapy associated cytokine release syndrome (CRS) and neurotoxicity","author":"Mayo Clinic","year":"2024","unstructured":"Mayo Clinic: Management of bispecific antibody therapy associated cytokine release syndrome (CRS) and neurotoxicity. mSMART. 2024. https:\/\/static1.squarespace.com\/static\/5b44f08ac258b493a25098a3\/t\/66c88650908cea1ed48d2741\/1724417617830\/mSMART+Teclistamab+guideline_V2_2024_rev.pdf"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2083479"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0028"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626616"},{"key":"e_1_3_5_14_2","doi-asserted-by":"crossref","unstructured":"Sandahl TB Soefje SA Fonseca R et al: Real-world safety and health care resource utilization of teclistamab under an outpatient model for step-up dosing administration. JCO Oncol Pract 21:702-709 2025","DOI":"10.1200\/OP-24-00489"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000970664.60500.7f"},{"key":"e_1_3_5_16_2","unstructured":"Wolters Kluwer: Medi-Span Price Rx pro online. Database. https:\/\/www.wolterskluwer.com\/en\/solutions\/medi-span\/price-rx"},{"key":"e_1_3_5_17_2","unstructured":"Medicare part B spending dashboard. Centers for Medicare and Medicaid Services. https:\/\/data.cms.gov\/search?keywords=Medicare%20Part%20B%20Spending%20by%20Drug&sort=Relevancy"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_3_5_19_2","volume-title":"FAQs on the 3-day payment window for services provided to outpatients who later are admitted as inpatients","year":"2024","unstructured":"FAQs on the 3-day payment window for services provided to outpatients who later are admitted as inpatients. Centers for Medicare and Medicaid Services, 2024. https:\/\/www.cms.gov\/files\/document\/se20024.pdf"},{"key":"e_1_3_5_20_2","article-title":"How will my costs be affected by inpatient or observation status?","author":"Backman M","year":"2025","unstructured":"Backman M: How will my costs be affected by inpatient or observation status? Health Insurance Organization, 2025. https:\/\/www.medicareresources.org\/faqs\/how-will-my-costs-be-affected-by-inpatient-or-observation-status\/","journal-title":"Health Insurance Organization"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01003-z"},{"key":"e_1_3_5_22_2","unstructured":"New medical services and new technologies. Centers for Medicare and Medicaid Services. https:\/\/www.cms.gov\/medicare\/payment\/prospective-payment-systems\/acute-inpatient-pps\/new-medical-services-and-new-technologies"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000199986.04094.35"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.12569"}],"updated-by":[{"DOI":"10.1200\/op-25-00383","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000}}],"container-title":["JCO Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/OP-24-00930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:59:22Z","timestamp":1768345162000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/OP-24-00930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1200\/OP-24-00930"],"URL":"https:\/\/doi.org\/10.1200\/op-24-00930","relation":{},"ISSN":["2688-1527","2688-1535"],"issn-type":[{"value":"2688-1527","type":"print"},{"value":"2688-1535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2024-11-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}